The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

The kicker? Pharma brands allocate less than 1% of their media budgets to audio — an enormous miss at a time when brands must be where their consumers are. While the pharma industry oversaturates ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

It is a pleasure for Amlan International to collaborate with Alembic Pharmaceuticals India that has a strong legacy with a global footprint. This agreement will lay the framework for cultivating ...

The Nippon India Pharma Fund - Growth has an AUM of 7637.04 crores & has delivered CAGR of 29.65% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.82%. The minimum ...

and Where a marketing company might own and manage a domain on behalf of a pharma brand, written proof from the brand is needed to confirm collaboration with the marketing company. Providing these ...

Every pharmaceutical marketer wants their brand campaign to be more emotional, but do we know why emotional marketing is important for brand adoption? To help you answer this question, this ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation, Inc. (HFI) and the Municipality of Malinao to launch a ...

The way healthcare providers (HCPs) navigate medication access is evolving rapidly. Pharma brands must be sure to keep up. Join us for this valuable webinar to take a deep dive into the latest ...

As the fight against drug ads could soon take center stage, big pharmaceutical brands will likely continue pivoting strategies and putting dollars into digital ads, content partnerships and ...

In June 2024, Junshi Biosciences convened the 2023 annual general meeting, the 2024 first class meeting of A shareholders and the 2024 first class meeting of H shareholders, and completed the election ...